Human HTRA2 PharmaGenie ELISA Kit (SBRS0684)

Assay Genie's HTRA2 immunoassay quantifies HtrA serine peptidase 2 (also called OMI or PRSS25), a mitochondrial serine protease linked to apoptosis regulation and to Parkinson's disease at the PARK13 susceptibility locus. The kit supports investigation of neurodegeneration, mitochondrial stress, and programmed cell death pathways across cell culture supernatants, plasma samples, and serum specimens. Researchers apply this 96-assay kit to biomarker discovery, patient cohort screening, and mechanistic studies comparing HTRA2 levels between disease and control groups. Each microplate arrives pre-coated with capture antibody and includes serial dilution standards for calibration, detection reagent, wash buffer, substrate solution, and stop reagent. Reagents should be refrigerated at 4 degrees C upon arrival, with substrate protected from light; the kit is for in vitro research use only. Sample volume is 100 uL per well, and no significant cross-reactivity is reported with related serine proteases such as HTRA1, HTRA3, or HTRA4.